Toxic potential of palytoxin

. 2015 Oct ; 35 (5) : 773-780. [epub] 20151022

Jazyk angličtina Země Čína Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid26489638
Odkazy

PubMed 26489638
DOI 10.1007/s11596-015-1506-3
PII: 10.1007/s11596-015-1506-3
Knihovny.cz E-zdroje

This review briefly describes the origin, chemistry, molecular mechanism of action, pharmacology, toxicology, and ecotoxicology of palytoxin and its analogues. Palytoxin and its analogues are produced by marine dinoflagellates. Palytoxin is also produced by Zoanthids (i.e. Palythoa), and Cyanobacteria (Trichodesmium). Palytoxin is a very large, non-proteinaceous molecule with a complex chemical structure having both lipophilic and hydrophilic moieties. Palytoxin is one of the most potent marine toxins with an LD50 of 150 ng/kg body weight in mice exposed intravenously. Pharmacological and electrophysiological studies have demonstrated that palytoxin acts as a hemolysin and alters the function of excitable cells through multiple mechanisms of action. Palytoxin selectively binds to Na(+)/K(+)-ATPase with a Kd of 20 pM and transforms the pump into a channel permeable to monovalent cations with a single-channel conductance of 10 pS. This mechanism of action could have multiple effects on cells. Evaluation of palytoxin toxicity using various animal models revealed that palytoxin is an extremely potent neurotoxin following an intravenous, intraperitoneal, intramuscular, subcutaneous or intratracheal route of exposure. Palytoxin also causes non-lethal, yet serious toxic effects following dermal or ocular exposure. Most incidents of palytoxin poisoning have manifested after oral intake of contaminated seafood. Poisonings in humans have also been noted after inhalation, cutaneous/systemic exposures with direct contact of aerosolized seawater during Ostreopsis blooms and/or through maintaining aquaria containing Cnidarian zoanthids. Palytoxin has a strong potential for toxicity in humans and animals, and currently this toxin is of great concern worldwide.

Zobrazit více v PubMed

Science. 1971 Apr 30;172(3982):495-8 PubMed

Arch Int Pharmacodyn Ther. 1982 Jul;258(1):146-54 PubMed

Toxicon. 2008 Mar 1;51(3):418-27 PubMed

Toxicon. 1996 Jun;34(6):643-52 PubMed

Toxicol Lett. 2014 Sep 17;229(3):440-50 PubMed

Biochem Pharmacol. 1991 Jun 21;42(1):17-23 PubMed

Toxicon. 1999 Nov;37(11):1521-7 PubMed

Clin Toxicol (Phila). 2010 Oct;48(8):839-44 PubMed

Nature. 1983 Mar 17-23;302(5905):212 PubMed

Toxicon. 2010 Aug 15;56(2):150-62 PubMed

FEBS J. 2007 Apr;274(8):1991-2004 PubMed

Toxicol Lett. 2009 Dec 15;191(2-3):253-9 PubMed

Mar Drugs. 2010 Jun 30;8(7):2021-37 PubMed

Lipids. 1998 Jun;33(6):627-32 PubMed

J Gen Physiol. 2004 Apr;123(4):357-76 PubMed

Bull Soc Pathol Exot. 1992;85(5 Pt 2):494-6 PubMed

J Emerg Med. 2011 Apr;40(4):397-9 PubMed

J Gen Physiol. 2006 Jul;128(1):103-18 PubMed

Mol Pharmacol. 1984 May;25(3):379-83 PubMed

Chem Rec. 2010 Mar;10(1):48-52 PubMed

Nihon Naika Gakkai Zasshi. 2001 Jul 10;90(7):1339-41 PubMed

Toxicon. 1998 Nov;36(11):1519-22 PubMed

J Neurochem. 1991 Oct;57(4):1276-80 PubMed

Toxicon. 1988;26(1):105-7 PubMed

PLoS One. 2012;7(6):e38139 PubMed

Fortschr Chem Org Naturst. 1985;48:81-202 PubMed

Toxicon. 2011 Mar 1;57(3):478-95 PubMed

Toxicon. 2009 Dec 15;54(8):1183-9 PubMed

Toxicon. 2011 Mar 1;57(3):376-89 PubMed

FEBS J. 2008 Dec;275(24):6067-74 PubMed

Experientia. 1977 Nov 15;33(11):1487-9 PubMed

Cancer Res. 1987 Sep 1;47(17):4618-22 PubMed

J Gen Physiol. 2010 Jul;136(1):63-82 PubMed

Toxicon. 1987;25(10):1121-4 PubMed

Toxicon. 2011 Apr;57(5):755-63 PubMed

Carcinogenesis. 1986 May;7(5):707-10 PubMed

Toxicon. 1974 Aug;12(4):427-33 PubMed

JAMA. 2005 Jun 1;293(21):2599-600 PubMed

Toxicon. 2011 Mar 1;57(3):400-7 PubMed

J Exp Biol. 2005 Nov;208(Pt 22):4345-54 PubMed

Toxicon. 2013 Dec 1;75:3-15 PubMed

Toxicon. 2011 Mar 1;57(3):470-7 PubMed

Toxicon. 1983;21(2):285-90 PubMed

Mar Pollut Bull. 2007 May;54(5):598-601 PubMed

Toxicon. 1989;27(11):1171-87 PubMed

Annu Rev Pharmacol Toxicol. 1986;26:117-42 PubMed

Gen Pharmacol. 1995 Jan;26(1):33-7 PubMed

Toxicon. 2008 Jun 15;51(8):1535-7 PubMed

Toxicon. 2011 Mar 1;57(3):368-75 PubMed

Intern Med. 1998 Mar;37(3):330-3 PubMed

Toxicon. 2009 Sep 1;54(3):244-51 PubMed

Rapid Commun Mass Spectrom. 2010 Sep;24(18):2735-44 PubMed

FEBS J. 2013 Aug;280(16):3906-19 PubMed

Toxicon. 2011 Mar 1;57(3):429-39 PubMed

Toxicon. 2011 Mar 1;57(3):390-9 PubMed

Mol Pharmacol. 1996 Jan;49(1):49-57 PubMed

Phys Biol. 2009 May 21;6(3):036010 PubMed

Toxicol Appl Pharmacol. 1975 Nov;34(2):214-23 PubMed

Toxicon. 1992 Nov;30(11):1449-56 PubMed

Toxicon. 1999 Jan;37(1):55-65 PubMed

Anal Chem. 2006 Sep 1;78(17):6153-9 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Comprehensive review of cardiovascular toxicity of drugs and related agents

. 2018 Jul ; 38 (4) : 1332-1403. [epub] 20180105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...